Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28050059)

Published in Dis Markers on December 05, 2016

Authors

Agnieszka Żyłka1, Agnieszka Gala-Błądzińska1, Paulina Dumnicka2, Piotr Ceranowicz3, Marek Kuźniewski4, Krzysztof Gil5, Rafał Olszanecki6, Beata Kuśnierz-Cabala7

Author Affiliations

1: St. Queen Jadwiga Clinical District Hospital No. 2, Rzeszow, Poland.
2: Department of Medical Diagnostics, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland.
3: Department of Physiology, Jagiellonian University Medical College, Krakow, Poland.
4: Department of Nephrology, Jagiellonian University Medical College, Krakow, Poland.
5: Department of Pathophysiology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
6: Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
7: Department of Diagnostics, Chair of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.

Articles cited by this

Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc (1985) 7.02

Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest (2005) 5.51

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis (2012) 3.56

Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol (2009) 3.01

Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J (2010) 2.89

Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int (2013) 2.48

Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr (2011) 2.01

Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care (2014) 1.79

Bias in associations of emerging biomarkers with cardiovascular disease. JAMA Intern Med (2013) 1.72

Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant (2004) 1.49

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol (2016) 1.07

Conventional markers of kidney function. Crit Care Med (2008) 1.05

Trends in the evidence level for the American Diabetes Association's "Standards of Medical Care in Diabetes" from 2005 to 2014. Diabetes Care (2015) 1.05

Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study. Endocrine (2009) 1.03

Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. Diabetes Res Clin Pract (2012) 1.01

Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients. PLoS One (2013) 0.97

The aging kidney. Kidney Int (1998) 0.93

Fibrates in the treatment of dyslipidemias--time for a reassessment. N Engl J Med (2011) 0.92

[Review article: Acute kidney injury in critical illness]. Can J Anaesth (2010) 0.90

Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes. Exp Ther Med (2013) 0.89

Characteristics of patients with type 2 diabetes of short duration in Poland: Rationale, design and preliminary results of the ARETAEUS1 study. Pol Arch Med Wewn (2009) 0.85

Day-to-day variation of urinary NGAL and rational for creatinine correction. Clin Biochem (2012) 0.83

Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications (2012) 0.83

Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients. Diabetes Metab Res Rev (2014) 0.80

Novel mechanisms and therapeutic options in diabetic nephropathy. Pol Arch Med Wewn (2009) 0.80

Changes in urine proteome accompanying diabetic nephropathy progression. Pol Arch Med Wewn (2015) 0.78

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Sao Paulo Med J (2015) 0.78

[The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria]. Nefrologia (2002) 0.77

[Effect of combination antihypertensive therapy on circadian blood pressure and metabolic parameters in patients with type 2 diabetes mellitus]. Kardiologiia (2014) 0.77

[Performance neutrophil gelatinase-associated lipocalin in clinical settings]. Przegl Lek (2013) 0.77